Top Health Tech Companies in Denver & Boulder, CO (365)
We’re powering a better social safety net. Building healthier and happier communities starts with supporting the whole person. That’s why Findhelp was founded in 2010: to connect all people in need to the programs that serve them with dignity and ease. Our software platform enables community organizations, governments, and businesses across industries to easily manage and coordinate care. From screening and...
Findhelp's Top Stability & Growth Strengths
Investor Backing & Capital Strength: In March 2026, TPG’s The Rise Fund invested about $250 million in Findhelp to scale products and go-to-market. This capital is described as fuel to expand the national network and technology.
Market Expansion: State and HIE initiatives are broadening reach, including Tennessee’s Medicaid statewide launch and California’s Manifest MedEx data-sharing integration. These deployments extend coverage to large member populations and embed social–clinical data exchange.
Product Line Growth: The October 2025 acquisition of Uno Health added benefits eligibility and enrollment, positioning the platform as more end‑to‑end. Behavioral-health integrations such as the nationwide SimplePractice connection further widen use cases.
We're building healthcare tech for a system that desperately needs it. Each year, millions of Americans deal with confusing changes to their Medicare plans that impact their prescriptions, access to care, and pocketbooks. These aren’t just inconveniences – they are potentially life-altering changes that leave seniors medically and financially vulnerable. Independent Medicare advisors play a crucial role in guiding seniors through this...
Spark Advisors's Top Stability & Growth Strengths
Investor Backing & Capital Strength: A $25M Series B on January 23, 2024 led by Viewpoint with participation from American Family Ventures and Primary, alongside a 4x valuation step-up from the 2021 Series A, signals solid capital support. Third-party databases list the same round.
Innovation-Driven Growth: New capabilities and feature releases (e.g., an AI Assistant and ongoing platform enhancements into 2026) are presented alongside sharp year-over-year AEP gains, pointing to product-led expansion. The company also highlights increased agent production and platform-driven efficiency.
Customer Loyalty & Retention: Materials cite +40% average agency enrollment growth after adopting the platform and an 84% average client retention rate. Expanding usage to 10,000+ agents and roughly 250,000 enrollments in 2025 further suggest deepening engagement.
.png)
American medicine is the best in the world. But the American healthcare system is challenged by high administrative costs that burden patients, health systems, and insurance companies with unnecessary expenses. We are focused on addressing those challenges. We use GenAI to improve the most pressing financial pain points in the revenue cycle. We’re one of the first companies to deploy GenAI...
AKASA's Top Stability & Growth Strengths
Investor Backing & Capital Strength: A third funding round reported as a Series C in June 2024, bringing total raised to $200M+, is presented as a scaling‑stage milestone and foundation for continued investment. This capital base aligns with ongoing product rollouts and market expansion efforts.
Strategic Partnerships: Cleveland Clinic expanded its enterprise deployment in 2025, and the Clinic’s own materials later highlighted systemwide use of AKASA’s generative‑AI tools for coding and documentation across U.S. locations. These multi‑site, referenceable wins indicate traction with major health systems.
Product Line Growth: Successive mid‑cycle launches in 2024–2025 (e.g., Authorization Advisor, AKASA Medical Coding, CDI Optimizer) highlight continued R&D and commercialization. This expansion signals a broader roadmap beyond an initial single‑product focus.
At Olympus, we put a lot of good back into the world, and what we do, really matters. We are committed to making people’s lives healthier, safer and more fulfilling every day by crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Everything we do at Olympus is a reflection of...
Health Sqyre is an online marketplace for medical equipment that provides patients with real-time assistance through transparent pricing and shopping tools to help them get the best price whether they want to pay in cash or use insurance. At Health Sqyre, patients can use their insurance to buy medical supplies online directly through Health Sqyre. Why customers love working with us: Transparent...
Intermountain Healthcare is a not-for-profit system of hospitals, surgery centers, doctors, and clinics that serves the medical needs of Utah, Idaho, Nevada, Colorado, Montana, and Kansas. Key medical services include cancer, heart, women and newborns, orthopedics, sports medicine, and more.
Intermountain Healthcare's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue grew in 2024 and continued through the first half of 2025, supported by increases in patient service and insurance premium revenue. Operating results improved alongside growth in premium/capitation and patient volumes.
Market Expansion: Expansion into Colorado via Select Health, new facilities such as the Lutheran Hospital campus, and the SCL Health merger broadened the system’s multi‑state footprint. Entry into new insurance markets and facility openings increased access and reach.
Diversified Revenue Streams: Growth in premium/capitation revenue through Select Health and clinically integrated networks complements patient service revenue. This payer‑provider mix aligns with a population‑health approach and supports resilience against single‑stream volatility.
MeBe is a provider of evidence-based therapies for children with autism and other special needs. Their mission is to empower families, professionals, and communities by educating and training them on evidence-based approaches, offering play-filled, research-based care across multiple disciplines.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
Cleerly is creating a new standard of care for heart disease through value-based, AI-driven precision diagnostic solutions with the goal of helping prevent heart attacks. Our technology goes beyond traditional measures of heart disease by enabling comprehensive quantification and characterization of atherosclerosis, or plaque buildup, in each of the heart arteries. Cleerly’s solutions are supported by more than a decade...
Cleerly's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent capital raises, including a $223M Series C (2022) and an additional ~$106M Series C-II in December 2024, provide fuel for commercialization and R&D. This funding base underpins scaling efforts alongside regulatory and reimbursement tailwinds.
Market Expansion: Coverage has been formalized by major payers (UnitedHealthcare, Cigna, Aetna) and Category I CPT 75577 became effective January 1, 2026, reducing billing friction and widening access. Health-system deployments (e.g., MemorialCare) and payer policy integration (e.g., UHC prior-authorization materials) indicate growing operationalization across sites.
Strategic Partnerships: Partnerships with groups like Cardiac Care Alliance and integrations such as PowerScribe, along with OEM ties (e.g., Canon), extend channel reach and ease workflow adoption. Product rollouts including lesion-level reporting showcased at RSNA 2025 signal maturing go-to-market readiness.
Apply online for Home Health LVN/LPN Nursing Jobs at Aveanna Healthcare - providing revolutionary behavioral health services to children and their families.
DocDock is a mobile app that connects patients with their medical providers. Healthcare professionals simply create an account and enter their profile information, and patients download the app to instantly connect and communicate with their healthcare team. Whether it's a simple appointment request or an important inquiry, DocDock makes it easy for providers to connect with patients and give them...
.png)
Youtopia is the first precision nourishment automation platform. We pair your diagnostic insights with personalized meal matching powered by AI. Enjoy chef-prepared meals tailored exactly to your nutrient needs, eliminating guesswork and simplifying health.
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access...
The Amaze solution combines employer-sponsored education with a subscription-based mobile service that provides employees and their families with everything they need to manage their own health care.
.png){kind=icon}
A social venture providing health an livelihood solutions to impoverished women globally. We develop low-cost, high-quality, beautiful, appropriate technology designed to meet the unique needs of women in resource-poor settings.
We’re data-driven. Curious. We’re developers, modelers, engineers, architects, and analysts. We come from diverse backgrounds and careers, driven by the desire to make people’s lives better and easier with technology. Our software solutions for the insurance industry continue to help evolve they way our clients approach the insurance marketplace.
PCM Trials is leading the way in mobile research and decentralized clinical trials. Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the flexibility to engage in research studies in the ways that work best for them and expanding opportunities...
Exer is a clinical AI company that helps healthcare teams drive clinical efficiencies and achieve higher patient volumes with their proprietary AI and computer vision platform designed to perform accurate, validated motion assessments. Without the need for sensors or wearables and effective across in-person and remote sessions, Exer AI improves patients’ lives and providers’ decision-making across complex care needs in...
STRIDE Community Health Center, formerly known as Metro Community Provider Network (MCPN), is a 501(c)(3) Federally Qualified Health Center (FQHC) with a 30-year history of providing primary care and other health-related services in a community-based setting.
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock. We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of...
IDEXX's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double‑digit top‑line increases in 2025 and early 2026, with Q1 and Q2 2026 up 14% and 10% reported, respectively, and full‑year 2026 revenue guidance raised. Growth is broad‑based across Companion Animal Group diagnostics, Water, and LPD.
Profitability: Margin expansion is attributed to recurring diagnostics volume, pricing, and productivity, translating into higher EPS and operating leverage. Guidance and quarterly updates highlight continued earnings growth if these drivers are maintained.
Strong Market Position & Advantage: The company is widely regarded as the category leader in companion‑animal diagnostics, reinforced by an integrated ecosystem of instruments, consumables, labs, imaging, and software. Independent analyses consistently place it at or near the top across key diagnostics segments, supporting durable advantage.
